Abbott Laboratories PE Ratio 2006-2018 | ABT

Current and historical p/e ratio for Abbott Laboratories (ABT) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Abbott Laboratories PE ratio as of October 19, 2018 is 24.05.
Abbott Laboratories PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-10-19 67.59 422.44
2018-09-30 73.36 $0.16 458.50
2018-06-30 60.72 $0.50 121.44
2018-03-31 59.37 $0.25 237.48
2017-12-31 56.28 $0.26 216.46
2017-09-30 52.37 $1.27 41.23
2017-06-30 47.45 $0.71 66.83
2017-03-31 43.08 $0.96 44.88
2016-12-31 37.03 $0.93 39.81
2016-09-30 40.51 $0.91 44.51
2016-06-30 37.42 $1.51 24.78
2016-03-31 39.58 $1.62 24.43
2015-12-31 42.23 $2.92 14.46
2015-09-30 37.60 $3.00 12.53
2015-06-30 45.66 $2.98 15.32
2015-03-31 42.88 $2.76 15.54
2014-12-31 41.44 $1.49 27.81
2014-09-30 38.08 $1.27 29.99
2014-06-30 37.25 $1.52 24.51
2014-03-31 34.87 $1.52 22.94
2013-12-31 34.51 $1.62 21.30
2013-09-30 29.76 $1.91 15.58
2013-06-30 31.15 $2.51 12.41
2013-03-31 31.43 $3.29 9.55
2012-12-31 27.89 $3.73 7.48
2012-09-30 29.09 $4.09 7.11
2012-06-30 27.25 $3.07 8.88
2012-03-31 25.80 $3.22 8.01
2011-12-31 23.57 $2.99 7.88
2011-09-30 21.34 $2.89 7.39
2011-06-30 21.87 $3.27 6.69
2011-03-31 20.29 $2.87 7.07
2010-12-31 19.73 $2.96 6.67
2010-09-30 21.43 $3.02 7.10
2010-06-30 19.11 $3.40 5.62
2010-03-31 21.43 $3.40 6.30
2009-12-31 21.89 $3.68 5.95
2009-09-30 19.98 $3.68 5.43
2009-06-30 18.92 $3.42 5.53
2009-03-31 19.10 $3.44 5.55
2008-12-31 21.30 $3.12 6.83
2008-09-30 22.90 $2.91 7.87
2008-06-30 21.00 $2.68 7.84
2008-03-31 21.79 $2.46 8.86
2007-12-31 22.13 $2.31 9.58
2007-09-30 21.07 $1.23 17.13
2007-06-30 20.98 $1.23 17.06
2007-03-31 21.80 $1.00 21.80
2006-12-31 18.98 $1.11 17.10
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $118.574B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.867B 19.45
Stryker (SYK) United States $63.182B 24.41
Boston Scientific (BSX) United States $50.532B 26.29
Baxter (BAX) United States $37.110B 25.26
Zimmer Biomet Holdings (ZBH) United States $25.314B 16.26
ResMed (RMD) United States $14.694B 29.17
Smith & Nephew SNATS (SNN) United Kingdom $14.608B 0.00
Canopy Growth (CGC) Canada $10.780B 0.00
Perrigo (PRGO) Ireland $9.837B 13.96
Bio-Rad Laboratories (BIO) United States $8.382B 53.82
Hill-Rom Holdings (HRC) United States $5.797B 19.66
Haemonetics (HAE) United States $5.495B 50.15
ICU Medical (ICUI) United States $5.418B 36.71
Insulet (PODD) United States $5.203B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.301B 0.00
Hutchison China MediTech (HCM) China $4.012B 0.00
Agios Pharmaceuticals (AGIO) United States $3.879B 0.00
Neogen (NEOG) United States $3.281B 49.69
NuVasive (NUVA) United States $3.191B 30.27
National Vision Holdings (EYE) United States $3.137B 69.28
Quidel (QDEL) United States $2.525B 51.73
NxStage Medical (NXTM) United States $1.815B 0.00
Phibro Animal Health (PAHC) United States $1.784B 25.40
Cardiovascular Systems (CSII) United States $1.263B 727.80
AtriCure (ATRC) United States $1.071B 0.00
VAREX IMAGING (VREX) United States $0.985B 16.09
Owens & Minor (OMI) United States $0.934B 9.99
OraSure Technologies (OSUR) United States $0.904B 59.08
Cerus (CERS) United States $0.887B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.874B 25.81
PetIQ (PETQ) United States $0.862B 28.18
Surmodics (SRDX) United States $0.842B 101.77
MacroGenics (MGNX) United States $0.792B 0.00
Omeros (OMER) United States $0.770B 0.00
Insys Therapeutics (INSY) United States $0.662B 0.00
Meridian Bioscience (VIVO) United States $0.660B 22.57
LeMaitre Vascular (LMAT) United States $0.542B 26.97
Lantheus Holdings (LNTH) United States $0.517B 16.07
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.445B 0.00
Quanterix (QTRX) United States $0.398B 0.00
Evolus (EOLS) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.323B 0.00
Cytosorbents (CTSO) United States $0.321B 0.00
Surface Oncology (SURF) United States $0.220B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.204B 0.00
Chimerix (CMRX) United States $0.173B 0.00
Fonar (FONR) United States $0.149B 7.32
Conatus Pharmaceuticals (CNAT) United States $0.144B 0.00
Chembio Diagnostics (CEMI) United States $0.137B 0.00
United-Guardian (UG) United States $0.080B 17.61
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.31
Imprimis Pharmaceuticals (IMMY) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.057B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00